Inflammation
Definition: Inflammation is a localized defensive immune reaction of the organism which tries to
localize and eliminate the pathogenic agent. Inflammatory response is a defense mechanism that
protect organisms from infection and injury.
Part of the innate immune response (physically, chemically and cellular defences against pathogen,
does not include the white blood cells.)
Comprises of vascular, metabolic, cellular changes, triggered by the entry of pathogen into healthy
tissues of the body
Etiology (the cause)
Exogenous causes
Physical agents (burns)
Chemical agents (toxic gases, acids, bases)
Biological agents (bacteria, virus, parasites)
Endogenous causes
Circulation disorders (thrombosis, infarction (inadequate blood supply to the affected area),
hemorrhage (bleeding or blood loss))
Enzymes activation (acute pancreatitis)
Metabolic products deposals or disposal (uric acid, urea)
Cardinal Inflammation signs (Primary or major symptom)
Rubor (redness)
Tumor (swelling)
Calor (heat)
Dolor (pain)
May or may not be followed by functio laesa, or loss of function (fifth sign of acute inflammation
by Galen)
Classes of inflammation
Acute (Intense)
Severe, intense, but usually short in duration
Most can be treated at home
Patients dies because of shortage of nurses
May suffer sickness, vomiting or acute pain, but they do not die.
E.g. Boil by S. Aureus
Chronic (Recurring)
Continual and recurring
Happen with chronic diabetes or arterial disease
Chronic pain can exacerbate (increase severity) or prolong the function disability of the
patients
Chronic atrial fibrillation is associated with an increased risk of death.
If left untreated, the condition may become chronic
E.g. Tuberculosis by M. tuberculosis
Characteristics of inflammations
Acute
Cause – Single injury
Duration – Takes up to hours or days
Presentative symptom – Increase permeability, exudation (fluid emitted by organisms through
pores or wound)
Main components Liquid, proteins/proteases and antiproteases/ PMN leucocytes,
macrophages
Connecting reaction – Thrombosis
Chronic
Causes Permanent present of the causing agent or bacteria, etc.
Duration Weeks, months, years (depending on the causing agent)
Presentative symptom Proliferative fibroblasts (contribute connective tissue proteins for
wound repair), no exudation
Main components Macrophage, Lymphocytes, Eosinophyl, granulocytes, connective tissue
hiperplasy (group of fibrous connective tissue lesions/injury)
Connecting reactions immune response
Microscopic changes
Dilation of vessels
Sludging of red blood cells
Fluid leaks into interstitium (a contiguous/in close proximity fluid-filled space between cells)
Implies increased permeability of vessels (to protein, not water)
Cells move into interstitium
Function of inflammation
Localize and destroy injuries agent and by products
Confining (enclose or stay in one area) effects of damage where total elimination is not possible
Repair and replace damaged tissues
Part 1: Fluid Definitions
A transudate has a low protein content usually caused by alterations in hydrostatic or oncotic
pressure. (colloid osmotic pressure, induced by protein or albumin) Implies a hydrostatic (pressure)
problem.
Occurs due to increased hydrostatic pressure or low plasma oncotic pressure.
E.g. Cirrhosis (complication of liver diseases like hepatitis and chronic alcoholism), nephrotic
syndrome (kidney disorder, damages small blood vessels that filter waste and excess water
causes body pass too much protein in urine), hypoalbuminemia (level of albumin in blood is
low)
An exudate has a high protein content, caused by increased vascular permeability. Implies an
inflammatory process.
Occurs due to inflammation and increased capillary permeability
E.g. Pneumonia (inflammation in air sacs of lungs), cancer, tuberculosis (Infection in lungs),
viral infection, autoimmune (disease where own immune system attacking own body)
Changes that combat injury
Vasodilation (Increases delivery, temperature and removes toxins)
Exudate (Delivers immunoglobulins, dilutes toxins, deliver fibrinogen, increases lymphatic
drainage)
Increased lymphatic drainage (Delivers bugs to phagocytes and antigens to immune system)
Cells (Removes pathogenic organisms, necrotic debris (premature death of cells), etc.)
Pain and loss of function (Enforces rest, reduces chance of further traumatic damage)
Mechanisms (Chemical Mediators)
Three phases:
1) Immediate early response (30mins)
Histamine
Released from mast cells (tissue cells of immune system and present in connective tissue),
basophils and platelets.
In response to many stimuli: Physical damage, immunologic reactions, anaphylatoxins
such as C3A and C5A, interleukin-1 (IL1), Factors from neutrophils and platelets
Effects: Largely vascular, pain, and not chemotactic (exhibiting chemotaxis the
movement of organism in response to chemical stimulus)
2) Immediate sustained response
Not always seen
Due to direct damage to endothelial cells
3) Delayed response (Peaks about 3 hours)
Many and varied chemical mediators, interlinked and of varying importance.
Incompletely understood
Important because possibility of therapeutic intervention.
Tissue damage
The inflammatory reaction takes place at microcirculation (circulation of blood in smallest vessels)
level and it is composed by the following changes:
Tissue damage
Cellular vascular and cellular response
Metabolic changes
Tissue repair
Following injury:
Huge interplay of acute phase proteins responsible for initiation of process
Mediators responsible for the following events of inflammation are released
E.g. Tissue macrophages, monocytes, mast cells, platelets, and endothelial cells are able to
produce a multitude of cytokines. Cytokines tissue Necrosis Factor-A (TNF-A) and Interleukin-
1 (IL1) are released first and initiate several cascades reaction.
Inflammatory mediators, TNF-A and IL-1
Responsible for the synthesis of IL-6, IL-8, and interferon gamma.
The proinflammatory interleukins either function directly on tissue or work via
secondary mediators to activate the coagulation cascade, complement cascade, and
the release of nitric oxide, platelet-activating factor, prostaglandins, and leukotrienes.
Cytokines, especially IL-6, stimulate the release of acute-phase reactants
(inflammation markers) such as C-reactive protein (CRP)
Induce fever and the release of stress hormones (norepinephrine, vasopressin,
activation of the renin-angiotensin-aldosterone system).
Vasodilation and increased permeability of blood vessels
Following tissue damage, blood vessels dilate in the area of damage.
Vasodilation (dilation of blood vessels which causes blood flow increase).
Chemical like inflammatory mediators released by damaged cells.
Associated with redness and heat.
Increased permeability permits defensive substances from the blood to enter the injured area.
Allows fluid movement and results in edema
Pain may cause by nerve damage, toxin irritation and edema pressure.
Types of inflammatory
mediators (contribute to
the event of inflammation)
Characteristics of inflammatory mediators
Prostaglandins
Ubiquitous (present everywhere)
lipid soluble molecules which contribute to vasodilation, capillary
permeability, and the pain and fever that accompany
inflammation.
Prostaglandins PGE1 and PGE2 induce inflammation and
potentiate (increase) the effects of histamine and other
inflammatory mediators.
Vasodilation of precapillary arterioles (edema), lower blood
pressure, modulates (adjust) receptors activity and affect
phagocytic activity of leukocytes
Leukotrienes
Produced by mast cells and basophils
Increase permeability of the blood vessels, stimulates the
chemotaxis and extravascularization (formation outside blood
vessels) of neutrophils, eosinophils, and monocytes
Assist in attachment of phagocytes to pathogens
and is an important inflammatory mediator in bronchial asthma
and anaphylaxis.
contraction of endothelial cells and dilation of postcapillary
venules)